Figure - available from: Frontiers in Surgery
This content is subject to copyright.
Deeks’ funnel plot. ESS, effective sample size.

Deeks’ funnel plot. ESS, effective sample size.

Source publication
Article
Full-text available
Background To assess the predictive value of radiomics for preoperative lymph node metastasis (LMN) in patients with biliary tract cancers (BTCs). Methods PubMed, Embase, Web of Science, Cochrane Library databases, and four Chinese databases [VIP, CNKI, Wanfang, and China Biomedical Literature Database (CBM)] were searched to identify relevant stu...

Similar publications

Article
Full-text available
Objective The purpose of this study was to evaluate the diagnostic performance of computed tomography (CT) scan–based radiomics in prediction of lymph node metastasis (LNM) in gastric cancer (GC) patients. Methods PubMed, Embase, Web of Science, and Cochrane Library databases were searched for original studies published until 10 November 2022, and...

Citations

... However, recent advances in radiology and computer vision, including radiomics and artificial intelligence, have leveraged CT imaging beyond visual interpretation (5). Artificial intelligence and deep learning (DL) based models on CT images achieve performance equivalent to or better than expert radiologists for gallbladder lesion detection and classification (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). ...
... DL-based automated lesion segmentation reduces human effort and facilitates end-to-end advanced radiological applications. In the context of GBC, automated segmentation may facilitate the seamless integration of radiomics, radiogenomics, and prognostication in clinical practice to improve disease management and outcomes (6)(7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19). Besides, accurate segmentation may also allow precise delivery of radiotherapy and avoid adjacent organ damage (32). ...
Article
Full-text available
Objectives To train and validate segmentation models for automated segmentation of gallbladder cancer (GBC) lesions from contrast-enhanced CT images. Materials and methods This retrospective study comprised consecutive patients with pathologically proven treatment naïve GBC who underwent a contrast-enhanced CT scan at four different tertiary care referral hospitals. The training and validation cohort comprised CT scans of 317 patients (center 1). The internal test cohort comprised a temporally independent cohort (n = 29) from center 1 (internal test 1). The external test cohort comprised CT scans from three centers [ (n = 85)]. We trained the state-of-the-art 2D and 3D image segmentation models, SAM Adapter, MedSAM, 3D TransUNet, SAM-Med3D, and 3D-nnU-Net, for automated segmentation of the GBC. The models’ performance for GBC segmentation on the test datasets was assessed via dice score and intersection over union (IoU) using manual segmentation as the reference standard. Results The 2D models performed better than 3D models. Overall, MedSAM achieved the highest dice and IoU scores on both the internal [mean dice (SD) 0.776 (0.106) and mean IoU 0.653 (0.133)] and external [mean dice (SD) 0.763 (0.098) and mean IoU 0.637 (0.116)] test sets. Among the 3D models, TransUNet showed the best segmentation performance with mean dice (SD) and IoU (SD) of 0.479 (0.268) and 0.356 (0.235) in the internal test and 0.409 (0.339) and 0.317 (0.283) in the external test sets. The segmentation performance was not associated with GBC morphology. There was weak correlation between the dice/IoU and the size of the GBC lesions for any segmentation model. Conclusion We trained 2D and 3D GBC segmentation models on a large dataset and validated these models on external datasets. MedSAM, a 2D prompt-based foundational model, achieved the best segmentation performance. Graphical abstract
... We explored the differences between models that utilize deep learning algorithms for feature extraction and those that employ HCR features. The analysis was limited to [30], biliary tract malignancies [31], and colorectal cancer [32]. For instance, the review by Windsor et al. discussed breast cancer LNM prediction using radiomics models based on different modalities and reported excellent pooled diagnostic accuracy metrics of Artificial Intelligence (AI)based models in LNM prediction across various imaging modalities [30]. ...
Article
Full-text available
Introduction Head and neck cancers are the seventh most common globally, with lymph node metastasis (LNM) being a critical prognostic factor, significantly reducing survival rates. Traditional imaging methods have limitations in accurately diagnosing LNM. This meta-analysis aims to estimate the diagnostic accuracy of Artificial Intelligence (AI) models in detecting LNM in head and neck cancers. Methods A systematic search was performed on four databases, looking for studies reporting the diagnostic accuracy of AI models in detecting LNM in head and neck cancers. Methodological quality was assessed using the METRICS tool and meta-analysis was performed using bivariate model in R environment. Results 23 articles met the inclusion criteria. Due to the absence of external validation in most studies, all analyses were confined to internal validation sets. The meta-analysis revealed a pooled AUC of 91% for CT-based radiomics, 84% for MRI-based radiomics, and 92% for PET/CT-based radiomics. Sensitivity and specificity were highest for PET/CT-based models. The pooled AUC was 92% for deep learning models and 91% for hand-crafted radiomics models. Models based on lymph node features had a pooled AUC of 92%, while those based on primary tumor features had an AUC of 89%. No significant differences were found between deep learning and hand-crafted radiomics models or between lymph node and primary tumor feature-based models. Conclusion Radiomics and deep learning models exhibit promising accuracy in diagnosing LNM in head and neck cancers, particularly with PET/CT. Future research should prioritize multicenter studies with external validation to confirm these results and enhance clinical applicability.
... 13,110 Apart from conventional imaging, radiomics may improve the prediction of lymph nodal metastasis. 111,112 Tumor-related imaging features that may suggest prognosis are discussed below. A study by Choi et al showed no significant relationship of tumor size with R0/R1/R2 resection. ...
Article
Full-text available
Gallbladder cancer (GBC) is a highly aggressive malignancy with dismal prognosis. GBC is characterized by marked geographic predilection. GBC has distinct morphological types that pose unique challenges in diagnosis and differentiation from benign lesions. There are no specific clinical or serological markers of GBC. Imaging plays a key role not only in diagnosis and staging but also in prognostication. Ultrasound (US) is the initial test of choice that allows risk stratification in wall thickening and polypoidal type of gallbladder lesions. US findings guide further investigations and management. Computed tomography (CT) is the test of choice for staging GBC as it allows comprehensive evaluation of the gallbladder lesion, liver involvement, lymph nodes, peritoneum, and other distant sites for potential metastases. Magnetic resonance imaging (MRI) and magnetic resonance cholangiopancreatography allow better delineation of the biliary system involvement. Contrast-enhanced US and advanced MRI techniques including diffusion-weighted imaging and dynamic contrast-enhanced MRI are used as problem-solving tools in cases where distinction from benign lesion is challenging at US and CT. Positron emission tomography is also used in selected cases for accurate staging of the disease. In this review, we provide an up-to-date insight into the role of imaging in diagnosis, staging, and prognostication of GBC.
... Original investigations have shown that radiomics features extracted from tumoral regions of interest can be utilized to detect the presence of lymph node metastasis in pancreatic ductal adenocarcinoma [17]. However, several issues have hindered wide-scale consideration of radiomics features so far, including the potential variations in feature extraction, selection, and utilization of radiomics features [18,19], and potential uncertainties caused by differences in methodologic quality of manuscripts, appropriateness of patient selection, and lack of large-scale, multicentertrained, and externally validated classifiers [20]. ...
Article
Full-text available
Lymph node metastases are associated with poor clinical outcomes in pancreatic ductal adenocarcinoma (PDAC). In preoperative imaging, conventional diagnostic modalities do not provide the desired accuracy in diagnosing lymph node metastasis. The current review aims to determine the pooled diagnostic profile of studies examining the role of radiomics features in detecting lymph node metastasis in PDAC. PubMed, Google Scholar, and Embase databases were searched for relevant articles. The quality of the studies was examined using the Radiomics Quality Score and Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) tools. Pooled results for sensitivity, specificity, likelihood, and odds ratios with the corresponding 95% confidence intervals (CIs) were calculated using a random-effect model (DerSimonian–Liard method). No significant publication bias was detected among the studies included in this meta-analysis. The pooled sensitivity of the validation datasets included in the study was 77.4% (72.7%, 81.5%) and pooled specificity was 72.4% (63.8, 79.6%). The diagnostic odds ratio of the validation datasets was 9.6 (6.0, 15.2). No statistically significant heterogeneity was detected for sensitivity and odds ratio (P values of 0.3 and 0.08, respectively). However, there was significant heterogeneity concerning specificity (P = 0.003). The pretest probability of having lymph node metastasis in the pooled databases was 52% and a positive post-test probability was 76% after the radiomics features were used, showing a net benefit of 24%. Classifiers trained on radiomics features extracted from preoperative images can improve the sensitivity and specificity of conventional cross-sectional imaging in detecting lymph node metastasis in PDAC. Graphical Abstract
... Furthermore, recently they have been found to predict histology, response to treatment, genetic signature, recurrence, and survival, among other features, in several pathologies, especially cancer [8,9]. In a recent meta-analysis, radiomics depicted a high level of predictive value for pre-operative lymph node metastasis in patients with biliary tract cancers; this study also showed that MRI-derived radiomics had a higher pooled sensitivity than CT [10]. ...
Article
Full-text available
Background: Radiomics refers to a recent area of knowledge that studies features extracted from different imaging techniques and subsequently transformed into high-dimensional data that can be associated with biological events. Diffuse midline gliomas (DMG) are one of the most devastating types of cancer, with a median survival of approximately 11 months after diagnosis and 4–5 months after radiological and clinical progression. Methods: A retrospective study. From a database of 91 patients with DMG, only 12 had the H3.3K27M mutation and brain MRI DICOM files available. Radiomic features were extracted from MRI T1 and T2 sequences using LIFEx software. Statistical analysis included normal distribution tests and the Mann–Whitney U test, ROC analysis, and calculation of cut-off values. Results: A total of 5760 radiomic values were included in the analyses. AUROC demonstrated 13 radiomics with statistical significance for progression-free survival (PFS) and overall survival (OS). Diagnostic performance tests showed nine radiomics with specificity for PFS above 90% and one with a sensitivity of 97.2%. For OS, 3 out of 4 radiomics demonstrated between 80 and 90% sensitivity. Conclusions: Several radiomic features demonstrated statistical significance and have the potential to further aid DMG diagnostic assessment non-invasively. The most significant radiomics were first- and second-order features with GLCM texture profile, GLZLM_GLNU, and NGLDM_Contrast.
Article
Full-text available
Objective Microsatellite instability (MSI) is a novel predictive biomarker for chemotherapy and immunotherapy response, as well as prognostic indicator in colorectal cancer (CRC). The current standard for MSI identification is polymerase chain reaction (PCR) testing or the immunohistochemical analysis of tumor biopsy samples. However, tumor heterogeneity and procedure complications pose challenges to these techniques. CT and MRI-based radiomics models offer a promising non-invasive approach for this purpose. Materials and methods A systematic search of PubMed, Embase, Cochrane Library and Scopus was conducted to identify studies evaluating the diagnostic performance of CT and MRI-based radiomics models for detecting MSI status in CRC. Pooled area under the curve (AUC), sensitivity, and specificity were calculated in RStudio using a random-effects model. Forest plots and a summary ROC curve were generated. Heterogeneity was assessed using I² statistics and explored through sensitivity analyses, threshold effect assessment, subgroup analyses and meta-regression. Results 17 studies with a total of 6,045 subjects were included in the analysis. All studies extracted radiomic features from CT or MRI images of CRC patients with confirmed MSI status to train machine learning models. The pooled AUC was 0.815 (95% CI: 0.784–0.840) for CT-based studies and 0.900 (95% CI: 0.819–0.943) for MRI-based studies. Significant heterogeneity was identified and addressed through extensive analysis. Conclusion Radiomics models represent a novel and promising tool for predicting MSI status in CRC patients. These findings may serve as a foundation for future studies aimed at developing and validating improved models, ultimately enhancing the diagnosis, treatment, and prognosis of colorectal cancer. Graphical Abstract